New Delhi, October 3 (IANS). A research has revealed that sugar and obesity can re-emerge in liver cancer. Liver cancer is the sixth most common cancer worldwide.
Research on hepatocellular carcinoma (HCC) was conducted by Osaka Metropolitan University. This is a type of liver cancer associated with hepatitis infection. It can cause relapse of liver cancer and is also the third leading cause of cancer-related death globally.
Obesity and diabetes are associated with metabolic syndrome. Which promote fat accumulation (steatotic liver disease), which can lead to liver cirrhosis and hepatocellular carcinoma (HCC).
However, the situation regarding the patient’s survival or recurrence of cancer due to obesity or diabetes is not clear.
The research team led by Dr. Hiroji Shinkawa of the University’s Graduate School of Medicine said, “Hepatocellular carcinoma is associated with a late but higher risk of recurrence in combination with obesity and sugar. Controlling obesity and sugar is important for prevention.
In research published in the journal Liver Cancer, the team analyzed 1,644 patients with hepatocellular carcinoma who had undergone liver resection surgery. On the basis of research, an attempt was made to find out what is the relationship between sugar diabetes, obesity and postoperative outcomes.
The results showed that the risk of recurrence of obesity was increased by approximately 1.5 times two years after the operation, and in case of diabetes the risk was 1.3 times higher.
The results showed that patients with obesity had a 3.8 times higher risk of getting cancer again five years after the operation, while those with diabetes had a 2 times higher risk.
Shinkawa said the findings could help lead to early detection of cancer recurrence and appropriate treatment.
Type 2 diabetes is often caused by obesity. These two conditions are often related to each other.
Recent research has shown that the number of adults suffering from obesity will increase sixfold over the next 40 years, while the number of people suffering from diabetes will reach 642 million by 2040.
–IANS
MKS/KR
